Search Result "HGSOC"
Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer
Journal: Current Gene Therapy
Volume: 20 Issue: 4 Year: 2020 Page: 313-320
Author(s): Hui Qu,Yu Xia,Xiuqin Li
Circ_0070203 Promotes Epithelial-mesenchymal Transition in OvarianSerous Cystadenocarcinoma through miR-370-3p/TGFβR2 Axis
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 19 Issue: 2 Year: 2024 Page: 233-246
Author(s):
Unusual Scenario: Ipsilateral Pelvic Lymph Node Metastasis in High-Grade Serous Ovarian Carcinoma without Peritoneal Extension - A CaseReport
Journal: Current Cancer Therapy Reviews
Volume: 20 Issue: 5 Year: 2024 Page: 510-516
Author(s):
Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance
Journal: Current Drug Targets
Volume: 21 Issue: 2 Year: 2020 Page: 167-178
Author(s): Ling Wang,Qi Wang,Yangchun Xu,Manhua Cui,Liying Han
Drugs Repurposing in High-Grade Serous Ovarian Cancer
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 42 Year: 2020 Page: 7222-7233
Author(s): Manuel Torralba,Rossella Farra,Marianna Maddaloni,Mario Grassi,Barbara Dapas,Gabriele Grassi
Frontline Management of Advanced Epithelial Ovarian Cancer: AComprehensive Statement by the Africa Middle East Cancer Inter-group[AMCI]
Journal: Current Women`s Health Reviews
Volume: 20 Issue: 1 Year: 2024 Page: 76-89
Author(s): Hamdy A. Azim
Targeting Mutant-p53 for Cancer Treatment: Are We There Yet?
Journal: Current Molecular Pharmacology
Volume: 17 Issue: 1 Year: 2024 Page: 1-16
Author(s): Dhi Vya Lim,Wei Hwei Woo,Jing Xuan Lim,Xin Yee Loh,Hui Ting Soh,Seng Yung Adrian Lim,Zheng Yang Lee,Hui Yin Yow,Sharina Binti Hamzah,Jhi Biau Foo
Determination of Both TP53 Mutation Status and the Amount of p53Protein has Limited Diagnostic Importance for Patients with OvarianCancer
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 24 Year: 2022 Page: 4293-4300
Author(s): Sebastian M. Klein,Nisar P. Malek
Mechanisms and Therapeutic Targets of microRNA-associated Chemoresistance in Epithelial Ovarian Cancer
Journal: Current Cancer Drug Targets
Volume: 16 Issue: 5 Year: 2016 Page: 429-441
Author(s): Lingyun Zhang,Lubna Nadeem,Kristin Connor,Guoxiong Xu
Currently Approved Poly (Adenosine Diphosphate-Ribose) Inhibitors in Ovarian Cancer: Current Status and Future Directions
Journal: Clinical Cancer Drugs
Volume: 5 Issue: 1 Year: 2018 Page: 3-12
Author(s): Gonzalo H. Giornelli,Pablo Mando